About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Impella Supported OPCABG | Clinical Trials | Clareo Health

Back to clinical trial search

Active Not RecruitingNCT04339452

Impella Supported OPCABG

The present study introduces a novel approach to coronary revascularization through the use of a short term minimally-invasive left ventricular assist device (LVAD) to minimize myocardial injury and e...

Lead sponsor: Lucian Archambault Durham III•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Sponsors

Lead Sponsor

Lucian Archambault Durham III

Collaborators

Abiomed Inc.

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Age ≥ 18 years old
•Ejection fraction ≤ 35%
•Symptomatic three vessel Coronary Artery Disease with target vessels that are amenable to bypass (as determined by the operating surgeon) or Left main disease
•Adequate Distal target caliber (as determined by the PI or operating surgeon)

Exclusion Criteria

•* Patients with structural heart disease requiring cardiopulmonary bypass
•* Patients with cardiogenic shock who require a period of short-term mechanical circulatory support
•* Patients with mechanical aortic valve
•* Patients with previous median sternotomy
•* Patients with evidence of non-viability on preoperative cardiac MRI or CT scan
•* Insufficient conduit
•* BMI over 50
•* Suspected or known pregnancy

Related studies

Phenotypic Classification of FMR With CMR

NCT05965258 · Nonischemic Congestive Cardiomyopathy, Functional Mitral Regurgitation, and more

Development of CIRC Technologies

NCT05654272 · Cardiovascular Diseases, Heart Failure, and more

RECRUITINGPhase 2

Venous Ethanol for Ventricular Tachycardia

NCT05511246 · Ventricular Tachycardia, Ischemic Cardiomyopathy

Enrolling By Invitation

Repeated Endocardial Mapping for Efficacy Assessment After Catheter Ablation for Ischemic Ventricular Tachycardia

NCT05713357 · Ischemic Cardiomyopathy, Ventricular Tachycardia

CWT Versus AT on Selected Cardiovascular Indices and Functional Capacity in Patients With Ischemic Cardiomyopathy.

NCT05674955 · Ischemic Cardiomyopathy

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: January 27, 2025Terms

Trial snapshot

StatusACTIVE_NOT_RECRUITING

Phase—

Enrollment30

Start dateMay 2022

Last updatedJan 27, 2025

Condition

Ischemic Cardiomyopathy

Locations shown

The Medical College of Wisconsin

Milwaukee, Wisconsin

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 27, 2025Data synced to Clareo: May 3, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions